ERIC WESTERLUND: Open Payments
NPI 1811018070 · ROCKWALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,043 in 42 payments from 13 companies in 2025. Trend: 2023 $1,128 · 2024 $513 · 2025 $1,043
Food & beverage: $1,043
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $178 |
| Sumitomo Pharma America, Inc. | 7 | $177 |
| Boston Scientific Corporation | 2 | $150 |
| Antares Pharma, Inc. | 7 | $132 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $119 |
| Endo USA, Inc. | 3 | $62 |
| CGG Medical Inc | 2 | $51 |
| Astellas Pharma US Inc | 2 | $40 |
| PFIZER INC. | 2 | $39 |
| Dendreon Pharmaceuticals LLC | 1 | $32 |
Products named: ERLEADA, XYOSTED, General - Erectile Dysfunction, Nubeqa, ORGOVYX, XTANDI, AVEED, GEMTESA.
Industry payments across TX — which companies pay providers there.
